Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 021323

Expand all

LEXAPRO (ESCITALOPRAM OXALATE)
EQ 5MG BASE
Marketing Status: Prescription

Active Ingredient: ESCITALOPRAM OXALATE
Proprietary Name: LEXAPRO
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 5MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N021323
Product Number: 001
Approval Date: Aug 14, 2002
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Prescription
Patent and Exclusivity Information

LEXAPRO (ESCITALOPRAM OXALATE)
EQ 10MG BASE
Marketing Status: Prescription

Active Ingredient: ESCITALOPRAM OXALATE
Proprietary Name: LEXAPRO
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N021323
Product Number: 002
Approval Date: Aug 14, 2002
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Prescription
Patent and Exclusivity Information

LEXAPRO (ESCITALOPRAM OXALATE)
EQ 20MG BASE
Marketing Status: Prescription

Active Ingredient: ESCITALOPRAM OXALATE
Proprietary Name: LEXAPRO
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 20MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N021323
Product Number: 003
Approval Date: Aug 14, 2002
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Prescription
Patent and Exclusivity Information